12 electrical-machine-design-"https:" "https:" "https:" "https:" "https:" Postdoctoral positions at Institut Pasteur
-
Paris, September 2026 Position: A post-doctoral position is available in the Guermonprez lab at Institut Pasteur Paris (“Dendritic cells and adaptive immunity” Unit, https://research.pasteur.fr/fr
-
The Machine Learning for Integrative Genomics team (https://research.pasteur.fr/en/team/machine-learning-for-integrative- genomics/) at Institut Pasteur, headed by Laura Cantini, works at
-
-career scientist to develop cutting-edge machine learning approaches for understanding and designing pathogen antigens. This is a unique opportunity to help shape a new research program at the intersection
-
to peptidoglycan in the mammalian host. FEMSMicrobiol Rev. 45(1):fuaa044. https://doi.org/10.1093/femsre/fuaa044 Wheeler R, PA Dias Bastos, O Disson, A Rifflet,I Galbanyi,J Spielbauer, M Berard, M Lecuit, IG Boneca
-
Post-Doctoral Researcher Position at the Institut Pasteur in Paris Open position at the Biology of Spirochetes Unit, https://research.pasteur.fr/en/team/biology-of-spirochetes/ in the department
-
Paris, Mai 2026 A 2-year, post-doctoral position is available in the Guermonprez lab at Institut Pasteur Paris (“Dendritic cells and adaptive immunity” Unit, Immunology Department https
-
addressed by harnessing advances in tissue engineering, via the design of new organ-on-chip models that mimic features and functions of human lymphoid tissues in vitro. In this project, we will take advantage
-
following skills: Strong interest in the field of neuroimaging, psychiatry and genetics. Computer skills: Strong level in the main informatics software (FSL, Freesurfer, fMRIprep) and coding languages (R
-
and spatial transcriptomics and epigenomics. More details: https://research.pasteur.fr/en/team/cellular-plasticity-in-age-related-pathologies/ Candidate profiles We are seeking highly motivated
-
models. Current treatment strategies for HBV are life-long and rarely curative. Finite antiviral and immunomodulatory therapeutic strategies are being pursued for an HBV functional cure to treat the 254